A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study

1. Ruiz-Borrego, M.
2. Jimenez, B.
3. Antolín, S.
4. García-Saenz, J.A.
5. Corral, J.
6. Jerez, Y.
7. Trigo, J.
8. Urruticoechea, A.
9. Colom, H.
10. Gonzalo, N.
11. Muñoz, C.
12. Benito, S.
13. Caballero, R.
14. Bezares, S.
15. Carrasco, E.
16. Rojo, F.
17. Martín, M.